CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 4 analysts with an average price target of $9.49. This is a potential upside of $7.67 (421.43%) from yesterday's end of day stock price of $1.82.

C4 Therapeutics 's activity chart (see below) currently has 66 price targets and 55 ratings on display. The stock rating distribution of CCCC is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.21% with an average time for these price targets to be met of 60.55 days.

Highest price target for CCCC is $10, Lowest price target is $3.5, average price target is $6.63.

Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 17-Dec-2025. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 2 are a HOLD (25%), 6 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Apr-2022

$5

$3.18 (174.73%)

$10

1 months 21 days ago
(17-Dec-2025)

0/7 (0%)

$2.95 (143.90%)

Buy Since 23-Sep-2025

$10

$8.18 (449.45%)

$8

4 months 15 days ago
(23-Sep-2025)

4/6 (66.67%)

$7.41 (286.10%)

147

Buy Since 13-Dec-2023

$8

$6.18 (339.56%)

$12

5 months 3 days ago
(04-Sep-2025)

4/10 (40%)

$5.33 (199.63%)

102

Hold Since 14-Feb-2025

$3.5

$1.68 (92.31%)

$4

11 months 4 days ago
(03-Mar-2025)

1/3 (33.33%)

$1.1 (45.83%)

196

Buy Since 27-Oct-2020

$14

$12.18 (669.23%)

$15

1 years 11 months 3 days ago
(04-Mar-2024)

1/3 (33.33%)

$3.32 (31.09%)

29

Show more analysts

Please expand the browser size to see the chart

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 60.55 days on average for the stock forecasts to be realized with a an average price target met ratio 36.21

Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

Derek Archila works at WELLS FARGO and has 2 price targets and 3 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Leah Rush Cann with highest potential upside - $76.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Colin Bristow with lowest potential downside - $1.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?